C1S and urticaria: However, the low complement C1 inhibitor is frequently caused by an underlying lymphoproliferative disease that raises protein consumption and an antibody against C1-INH that causes an excess of bradykinin. Bradykinin-associated angioedema has the following characteristics: longer duration, increased severity of clinical symptoms and is not associated with urticaria.